OPKO and Entera partner to develop obesity pill
OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other disorders, the companies said on Monday.
Zepbound copycats remain online despite FDA ban
Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...
The Manila Times5d
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
EBX-102-02 is a next-generation full-spectrum microbiome product that contains a high-diversity microbiome consortium, stabilised within a dried, off-white odourless powder. EBX-102-02 is designed to ...
PBS6d
The Puerto Rico Pill Trials
After the success of the preliminary Boston trials for the Pill in 1954 and 1955 ... little mud hole"), had been razed to build clean, white seven-story buildings, and the new residents were ...
Ludington Daily News2d
Montague girls season ends against Spring Lake in MHSAA district final
Cloudy skies early will become partly cloudy later in the day. Temps nearly steady in the low to mid 30s. Winds NNW at 10 to 20 mph. Cloudy with rain developing later in the day. High 48F. Winds SE at ...
NPR3d
On Point
March 12, 2025 • Alaska's Glacier Bay National Park was first designated a national monument a century ago. Even with climate change, Glacier Bay has a surprising story to tell about nature's ...